Study Details
Testing the Drug Barzolvolimab for People with Chronic Spontaneous Urticaria
(IRB#: IRB_00179700)
Chronic Spontaneous Urticaria causes chronic hives that last for 6 weeks or more and appear 3-5 times a week. This study will test a drug called Barzolvolimab for people with this condition. The study wants to see if it will help people and is safe. People in the study will be randomly chosen to receive Barzolvolimab or a placebo. A placebo looks like the drug but does not have the medication. Being in the study requires completing surveys and attending up to 19 in-person visits at the study clinic for about 72 weeks. Medical tests will be done during the study to track the health of participants.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 18 years and older
- Diagnosis of Chronic Spontaneous Urticaria for at least 6 months before participation
- Have at least hives 6 weeks before participation
- Taking antihistamines (medication to relieve symptoms of allergies) for 4 weeks before participation
- Able to attend in person at the study clinic
Exclusion Criteria
- Any medical condition affects participation
- Any use of specific medication not allowed during the study
- Any use of Barzolvolimab or a medication like Barzolvolimab before participation
- History of cancer in the last 5 years
- Pregnant or breast feeding
Will I be paid for my time?
Yes
IRB#: IRB_00179700
PI: Mili Shum
Department: DERMATOLOGY
Approval Date: 2025-03-26 06:00:00
Specialties: Allergy and Clinical Immunology, Dermatology
I am Interested